Baseline parameter at admission | SAVR (n = 42) | TAVR (n = 78) | P value |
---|---|---|---|
Age (year, mean ± SD) | 77.6 ± 4.6 | 78.6 ± 4.8 | 0.316 |
Sex (male:female) | 28:14 | 58:20 | 0.372 |
Medical condition (no., % of total) | |||
Diabetes | 16 (38.1%) | 27 (34.6%) | 0.705 |
Hypertension | 37 (88.1%) | 71 (91.0%) | 0.61 |
Previous stroke | 3 (7.1%) | 5 (6.4%) | 0.878 |
Peripheral vascular disease | 12 (28.6%) | 22 (28.2%) | 0.966 |
Pacemaker | 2 (4.8%) | 3 (3.8%) | 0.811 |
STS predicted risk of mortality score (mean ± SD) | 5.3 ± 2.4 | 6.2 ± 2.4 | 0.055 |
New York Heart Association class (no., % of total) | |||
II | 17 (40.5%) | 29 (37.2%) | 0.833 |
III | 22 (52.4%) | 41 (52.6%) | |
IV | 3 (7.1%) | 8 (10.3%) | |
C-HADS depression (no., % of total) | |||
mean ± SD | 7.9 ± 2.9 | 7.1 ± 3.1 | 0.156 |
≤ 7 | 18 (42.9%) | 42 (53.8%) | 0.833 |
8–10 | 12 (28.6%) | 19 (24.4%) | |
≥ 11 | 12 (28.6%) | 17 (21.8%) | |
C-HADS anxiety (no., % of total) | |||
mean ± SD | 7.5 ± 2.5 | 6.9 ± 2.6 | 0.252 |
≤ 7 | 21 (50%) | 46 (59.0%) | 0.194 |
8–10 | 14 (33.3%) | 27 (34.6%) | |
≥ 11 | 7 (16.7%) | 5 (6.4%) | |
WHOQOL-OLD (mean ± SD) | 60.9 ± 11.5 | 59.5 ± 12.7 | 0.552 |
CFS (no., % of total) | |||
mean ± SD | 4.4 ± 1.8 | 4.2 ± 1.7 | 0.471 |
1–3 | 15 (35.7%) | 32 (41.0%) | 0.773 |
4–7 | 27 (64.3%) | 46 (59.0%) | |
8–9 | 0 | 0 |